Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Income

v3.22.2.2
Consolidated Condensed Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Oct. 01, 2022
Sep. 25, 2021
Oct. 01, 2022
Sep. 25, 2021
Income Statement [Abstract]        
Net revenue $ 15,338 $ 19,192 $ 49,012 $ 58,496
Cost of sales 8,803 8,446 27,646 25,690
Gross margin 6,535 10,746 21,366 32,806
Research and development 4,302 3,803 13,064 11,141
Marketing, general and administrative 1,744 1,674 5,296 4,601
Restructuring and other charges 664 42 (460) 2,597
Operating expenses 6,710 5,519 17,900 18,339
Operating income (loss) (175) 5,227 3,466 14,467
Gains (losses) on equity investments, net (151) 1,707 4,082 2,370
Interest and other, net 138 (76) 1,016 (328)
Income (loss) before taxes (188) 6,858 8,564 16,509
Provision for (benefit from) taxes (1,207) 35 (114) 1,264
Net income $ 1,019 $ 6,823 $ 8,678 $ 15,245
Earnings per share - Basic (in dollars per share) $ 0.25 $ 1.68 $ 2.11 $ 3.76
Earnings per share - Diluted (in dollars per share) $ 0.25 $ 1.67 $ 2.10 $ 3.73
Weighted average shares of common stock outstanding:        
Basic (shares) 4,118 4,061 4,104 4,055
Diluted (shares) 4,125 4,086 4,123 4,089